Biohaven Ltd. (BHVN)
11.53
+0.09
(+0.79%)
USD |
NYSE |
Dec 12, 16:00
11.47
-0.06
(-0.52%)
After-Hours: 20:00
Biohaven EPS Diluted (Quarterly): -1.639 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Exelixis, Inc. | 0.695 |
| Nektar Therapeutics | -1.875 |
| Stereotaxis, Inc. | -0.0737 |
| Xencor, Inc. | -0.081 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -173.44M |
| Total Expenses (Quarterly) | 173.44M |
| Enterprise Value | 1.583B |
| Earnings Yield | -65.90% |
| Normalized Earnings Yield | -66.06 |